Decoy Therapeutics (DCOY) is trading at $12.38 (+124.3%) in pre-market, rebounding sharply from its prior close of $5.52 following news of a significant financing deal.
- The surge follows the announcement on June 26, 2026, of a private placement financing expected to provide $3.5 million in upfront gross proceeds, with potential for up to $21 million more through milestone-based warrants.
- This financing is anticipated to close on or about June 29, 2026, clearing a path to advance its lead asset into clinical trials.